The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges
Prostate cancer (PCa) is the most common cause of malignancy in males and the second leading cause of cancer mortality in United States. Current treatments for PCa include surgery, radiotherapy, and androgen-deprivation therapy. Eventually, PCa relapses to an advanced castration-resistant PCa (CRPC)...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Asian Journal of Urology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388216300674 |